Ozempic is FDA approved for type 2 diabetes management and has extensive data supporting its ability to reduce HbA1c by 1.0% to 1.8% depending on baseline levels and dose
Where the anti-obesity benefit is included in the employer plan, Harvard Pilgrim requires prior authorization with BMI 30 or higher (or 27 with a weight-related comorbidity such as hypertension, T2D, dyslipidemia, or sleep apnea), documented lifestyle program participation, and demonstrated weight-loss progress for renewal
Within days to weeks of stopping treatment, patients generally experience return of appetite to pre-treatment levels, faster gastric emptying, and loss of the medication's effects on satiety signaling
To avoid this, systematically move between different areas and within each area, spacing each injection at least 12 cm from the previous site, in line with FIT UK Injection Technique Recommendations
Actual peer-reviewed research in indexed medical journals
These pleiotropic effects highlight their potential to transform precision medicine across a spectrum of metabolic and non-metabolic diseases
